Innate immune mechanisms of the host response to Coccidioides
宿主对球孢子菌反应的先天免疫机制
基本信息
- 批准号:10356728
- 负责人:
- 金额:$ 32.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-24 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAntifungal AgentsAntigen PresentationAspergillusBindingBiochemicalBlood CellsBrainCandidaCell CommunicationCell physiologyCellsCessation of lifeClinicalClinical ImmunologyCoccidioidesCoccidioides immitisCoccidioidomycosisCollaborationsCommunicable DiseasesDataDendritic CellsDiseaseDisease modelEquilibriumGene ExpressionGenesGenetic DeterminismGenetic PolymorphismGenetic TranscriptionGenetic studyGoalsHumanImmuneImmune System DiseasesImmune responseImmunityImmunogeneticsImmunoglobulinsImmunologicsInfectionInflammasomeInflammationInflammatoryInnate Immune ResponseInterleukin-1Knockout MiceLectinLeukocytesLightMediatingMicrobiologyMolecularMorbidity - disease rateMusMycosesMyeloid CellsNatural ImmunityNatural Killer CellsOutcomePathway interactionsPatientsPattern RecognitionPlayPredispositionProcessProductionProteinsRNARecording of previous eventsResearch PersonnelRiskRoleSialic AcidsSignal PathwaySignal TransductionSkinSourceStructureTranscriptional RegulationTranslationsVirulenceVirulence FactorsWorkadaptive immune responseadverse outcomebasebonechemokinecollaborative approachcytokinedectin 1experiencegain of functionimprovedin vivoinnate immune mechanismsinnate immune pathwaysinterestmacrophagemouse modelneutrophilnew therapeutic targetoutcome predictionpathogenpathogenic funguspreventprognostic indicatorprogramsreceptorreceptor bindingrecruitresponsescreeningsialic acid binding Ig-like lectinstem
项目摘要
Summary – Project 1
Project 1 is a new collaborative approach to understand the innate immune pathways involved in the
host response to Coccidioides, an invasive pathogenic fungus resulting in 20,000 infections in the US annually.
Only 1-2% of patients infected develop a severe and frequently lethal form, known as disseminated
coccidiomycosis which affects brain, bones, and/or skin and usually requires lifelong therapy with anti-fungal
drugs to prevent death and reduce morbidity. The factors determining the course of infected patients are not
known, but it is likely that there is innate immune dysregulation in many of these patients that is genetically
determined. While we have learned a great deal about the normal host response to common invasive fungal
pathogens such as Candida and Aspergillus, there still remains much to be learned about Coccidioides.
We will utilize a multi-pronged approach focusing on each major step of the innate immune response
including 1) pattern recognition 2) cytokine responses and 3) pathogen processing, and on the specific
molecular levels of this response such as RNA transcriptional regulation and cross-talk, protein translation and
post-translation processing, as well as cell function and cell-cell interaction. To accomplish our goals, we have
built a coalition of biomedical investigators at UCSD with a long history of collaboration, but a relatively new
shared interest in Coccidioides and an expert with more than 40 years of experience studying Coccidioides.
Aim 1. Define the mechanisms by which Dectin-1 and inhibitory Siglecs regulate human myeloid cell
responses to coccidioides. Using myeloid cells from normal human donors we will characterize how human
dectin-1 recognition of Coccidioides regulates gene expression programs. Using gain-of-function studies we will
determine how iSiglec engagement inhibits Dectin-1 signaling. Finally, we will determine how human
polymorphisms in Dectin-1 signaling pathways alter the cellular immune response to Coccidioides.
Aim 2. Identify the cellular source of IL-1 and IL-1 in coccidioides infection and the inflammasome
dependent and independent pathways controlling their processing and release
Using human blood cells from cocci patients and controls or cells from specific knockout mice challenged
with killed Coccidioides spherules, we will examine and shed light on the role of inflammasome and non-
inflammasome mediated cleavage and release of IL-1 and IL-1 in the host response to Coccidioides infection.
Aim 3. Investigate the contribution of activating and inhibitory receptors to inter-leukocyte shuttling of
coccidioides endospores. We will investigate the control of Coccidioides endospore shuttling by activating and
inhibitory receptors on mouse and human neutrophils, macrophages, and dendritic cells.
The overall impact of this work will improve our understanding of the immune response to Coccidioides
and improve our ability to predict outcomes in patients with coccidiomycosis.
摘要 - 项目1
项目1是一种新的协作方法,可以了解涉及的先天免疫途径
宿主对球虫剂的反应,Coccidioides是一种侵入性的致病真菌,导致美国年度20,000次感染。
只有1-2%的患者受感染的患者发展出严重且经常致死的形式,称为传播
影响大脑,骨骼和/或皮肤的球虫病,通常需要终身治疗抗真菌
药物预防死亡并减少发病率。确定感染患者进程的因素不是
已知,但许多患者可能存在先天免疫失调
决定。虽然我们已经对普通侵入性真菌的正常宿主反应学到了很多东西
诸如念珠菌和曲霉等病原体,关于球虫剂仍有很多值得了解的地方。
我们将利用一种多管齐下的方法,重点是先天免疫反应的每个主要步骤
包括1)模式识别2)细胞因子反应和3)病原体加工,以及特定的
该反应的分子水平,例如RNA转录调节和串扰,蛋白质翻译和
翻译后处理以及细胞功能和细胞 - 细胞相互作用。为了实现我们的目标,我们有
在UCSD建立了一个生物医学调查员联盟,并具有悠久的协作历史,但相对新
对球虫毒剂的兴趣共同兴趣,并且拥有超过40年研究球虫毒剂的专家。
目标1。定义dectin-1和抑制性siglecs调节人髓样细胞的机制
对球虫剂的反应。使用来自正常人类供体的髓样细胞,我们将表征人类
Coccidioides的Dectin-1识别调节基因表达程序。使用功能收益研究,我们将
确定ISIGLEC参与如何抑制Dectin-1信号传导。最后,我们将确定人类
Dectin-1信号通路中的多态性改变了对球虫剂的细胞免疫响应。
AIM 2。确定球虫下感染和炎症体中IL-1和IL-1的细胞来源
控制其处理和释放的依赖和独立的途径
使用来自球菌患者的人体血细胞,对照组或特定敲除小鼠的细胞挑战
随着杀死球球菌的杀伤,我们将检查并阐明炎性体和非 -
在宿主对球虫下感染的宿主反应中,炎性体介导的裂解和IL-1和IL-1的释放。
目标3。研究激活和抑制受体对白细胞间穿梭的贡献
球孢子内孢子。我们将通过激活和
小鼠和人类中性粒细胞,巨噬细胞和树突状细胞上的抑制受体。
这项工作的总体影响将提高我们对Coccidioides免疫增强响应的理解
并提高我们预测球霉症患者的结局的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAROLD M HOFFMAN其他文献
HAROLD M HOFFMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAROLD M HOFFMAN', 18)}}的其他基金
Innate immune mechanisms of the host response to Coccidioides
宿主对球孢子菌反应的先天免疫机制
- 批准号:
10554376 - 财政年份:2022
- 资助金额:
$ 32.67万 - 项目类别:
Neutrophil Survival and Demise During Inflammatory States
炎症状态下中性粒细胞的存活和死亡
- 批准号:
10651795 - 财政年份:2021
- 资助金额:
$ 32.67万 - 项目类别:
Neutrophil Survival and Demise During Inflammatory States
炎症状态下中性粒细胞的存活和死亡
- 批准号:
10270899 - 财政年份:2021
- 资助金额:
$ 32.67万 - 项目类别:
Neutrophil Survival and Demise During Inflammatory States
炎症状态下中性粒细胞的存活和死亡
- 批准号:
10470243 - 财政年份:2021
- 资助金额:
$ 32.67万 - 项目类别:
Targeting inflammasome mediated disorders with green tea
用绿茶治疗炎症小体介导的疾病
- 批准号:
8084189 - 财政年份:2010
- 资助金额:
$ 32.67万 - 项目类别:
Targeting inflammasome mediated disorders with green tea
用绿茶治疗炎症小体介导的疾病
- 批准号:
7979296 - 财政年份:2010
- 资助金额:
$ 32.67万 - 项目类别:
Novel regulatory role of cryopyrin in inflammation
Cryopyrin 在炎症中的新调节作用
- 批准号:
6915149 - 财政年份:2004
- 资助金额:
$ 32.67万 - 项目类别:
Novel regulatory role of cryopyrin in inflammation
Cryopyrin 在炎症中的新调节作用
- 批准号:
6813842 - 财政年份:2004
- 资助金额:
$ 32.67万 - 项目类别:
The role of cryopyrin in autoinflammatory diseases
隐热蛋白在自身炎症性疾病中的作用
- 批准号:
6778348 - 财政年份:2002
- 资助金额:
$ 32.67万 - 项目类别:
The role of cryopyrin in autoinflammatory diseases
隐热蛋白在自身炎症性疾病中的作用
- 批准号:
6937116 - 财政年份:2002
- 资助金额:
$ 32.67万 - 项目类别:
相似国自然基金
典型唑类抗真菌剂在斑马鱼中的富集代谢规律及其性腺激素干扰效应研究
- 批准号:21507163
- 批准年份:2015
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
群体感应系统阻遏抗真菌剂藤黄绿菌素生物合成的分子机制
- 批准号:31270083
- 批准年份:2012
- 资助金额:82.0 万元
- 项目类别:面上项目
抗真菌剂藤黄绿菌素生物合成自诱导的分子机理研究
- 批准号:30800009
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Human Immunomics & Trained Immunity in Persistent Candidemia
人类免疫组学
- 批准号:
10551710 - 财政年份:2023
- 资助金额:
$ 32.67万 - 项目类别:
The unfolded protein response as a therapeutic target for fungal keratitis
未折叠蛋白反应作为真菌性角膜炎的治疗靶点
- 批准号:
10624339 - 财政年份:2022
- 资助金额:
$ 32.67万 - 项目类别:
Innate immune mechanisms of the host response to Coccidioides
宿主对球孢子菌反应的先天免疫机制
- 批准号:
10554376 - 财政年份:2022
- 资助金额:
$ 32.67万 - 项目类别:
MHC-II deficient Langerhans cells with compensatory Tc17 plasticity in oral candidiasis
MHC-II 缺陷朗格汉斯细胞在口腔念珠菌病中具有补偿性 Tc17 可塑性
- 批准号:
10194461 - 财政年份:2020
- 资助金额:
$ 32.67万 - 项目类别:
MHC-II deficient Langerhans cells with compensatory Tc17 plasticity in oral candidiasis
MHC-II 缺陷朗格汉斯细胞在口腔念珠菌病中具有补偿性 Tc17 可塑性
- 批准号:
10056498 - 财政年份:2020
- 资助金额:
$ 32.67万 - 项目类别: